1
Jaume Pons, Arnon Rosenthal: Anti-NGF antibodies and methods using same. Pfizer, Gregg Benson, Marie A Aucoin, November 11, 2008: US07449616 (40 worldwide citation)

The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain ...


2
Arnon Rosenthal: Antibodies to neurotrophic factor-4 (NT-4). Genentech, Timothy E Torchia PhD, December 30, 1997: US05702906 (27 worldwide citation)

A novel polypeptide, designated neurotrophic factor-4 (NT-4), has been identified by PCR amplification of human genomic DNA. Provided herein is nucleic acid encoding NT-4 useful in diagnostics and in the recombinant preparation of NT-4. Also provided herein are nucleic acids encoding naturally occur ...


3
Jaume Pons, Arnon Rosenthal: Anti-NGF antibodies and methods using same. Pfizer, Gregg C Benson, Marie A Aucoin, February 2, 2010: US07655232 (21 worldwide citation)

The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain ...


4
Arnon Rosenthal, David L Shelton, Patricia A Walicke: Anti-NGF antibodies and methods using same. Pfizer, Gregg Benson, Marie A Aucoin, August 4, 2009: US07569364 (21 worldwide citation)

The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain ...


5
Frederic de Sauvage, Arnon Rosenthal: Fused. Genentech, Craig G Svoboda, February 8, 2000: US06022708 (21 worldwide citation)

The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing, immunoadhesins, agonists and antagonists to human & vertebrate fused.


6
Arnon Rosenthal, Mary A Hynes, Weilan Ye: Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells. Genentech, David A Carpenter, August 21, 2001: US06277820 (20 worldwide citation)

The present invention relates to neuronal formation and methods of treating diseases characterized by abnormalities in the activity of dopaminergic (DA) and serotonergic (5HT) neurons. In particular, the invention relates to a method of forming serotonergic neurons in vitro by contacting neuroprogen ...


7
Arnon Rosenthal: Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production. Genentech, Sean A Johnston, November 15, 1994: US05364769 (19 worldwide citation)

A novel polypeptide, designated neurotrophic factor-4 (NT-4), has been identified by PCR amplification of human genomic DNA. Provided herein is nucleic acid encoding NT-4 useful in diagnostics and in the recombinant preparation of NT-4. NT-4 is used in the treatment of nerve cells and in diagnostic ...


8
Joerg Zeller, Kristian T Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Leigh Jones Collier, Arnon Rosenthal: Antagonist antibodies directed against calcitonin gene-related peptide and methods using same. Rinat Neuroscience Corporation, Jennifer Kispert, Ian J S Lodovice, August 30, 2011: US08007794 (18 worldwide citation)

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies deriv ...


9
Joerg Zeller, Kristian T Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Lee Jones Collier, Arnon Rosenthal: Methods of using anti-CGRP antagonist antibodies. Labrys Biologics, Wilson Sonsini Goodrich & Rosati, November 19, 2013: US08586045 (16 worldwide citation)

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies deriv ...


10
Joerg Zeller, Kristian T Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal: Methods of treating vasomotor symptoms using antibodies. Labrys Biologics, Wilson Sonsini Goodrich & Rosati, May 27, 2014: US08734802 (14 worldwide citation)

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies deriv ...